Sativex – Cannabis & MS

According to a report from Reuters, Sativex® is to receive approval in the UK track for multiple sclerosis in Q2 this year!

Regulators had concluded there weren’t any major quality, safety or efficacy issues still to be resolved.  Discussions are now focusing on points of clarification related to the patient information leaflet.  Sativex will be marketed by Bayer in the UK and by the Spanish Almirall in the rest of Europe. Following approval in the UK and Spain, submissions for approval will be then made in additional European countries during 2010 under the mutual recognition procedure.

Sativex is an oral spray containing a cannabis extract and has shown to alleviate symptoms of spasticity and pain for MS patients.


2 Comments (+add yours?)

  1. Peter Reynolds
    Jul 15, 2010 @ 21:58:24

    Sativex is sold to the NHS at five times the street price of cannabis.


    • sofija
      Jul 15, 2010 @ 23:59:23

      Hi Pete! thanks for the update!! : )
      it is “a bit” pricey…Gosh… then what is the point.. One might as well just (continue to) get it on the street right? ; )


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: